NORTHAMPTON, MA / ACCESS Newswire / February 6, 2025 / Jazz Pharmaceuticals, Inc.
Join the Movement for Awareness and Support on World Cancer Day
It is estimated that about 1 in 5 people will develop cancer in their lifetime. Receiving a cancer diagnosis can feel like your life, and the lives of those around you, have been flipped upside down.
In honor of #WorldCancerDay, we're participating in the Union for International Cancer Control (UICC)'s Upside Down Challenge to rally behind the unique voices of every patient and family member impacted by cancer and help bring much-needed awareness to this challenging disease.
Learn how you can get involved today and use the hashtag #UnitedByUnique
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq:JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing potentially life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
View additional multimedia and more ESG storytelling from Jazz Pharmaceuticals, Inc. on 3blmedia.com.
Contact Info:
Spokesperson: Jazz Pharmaceuticals, Inc.
Website: https://www.3blmedia.com/profiles/jazz-pharmaceuticals-inc
Email: info@3blmedia.com
SOURCE: Jazz Pharmaceuticals, Inc.
View the original
press release on ACCESS Newswire
